Caris Life Sciences®, a molecular science and technology company, announced that the Herbert Irving Comprehensive Cancer Center has joined Caris’ Precision Oncology Alliance™. The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients. Read more.
Caris Precision Oncology Alliance Adds Columbia University Irving Medical Center to its Collaborative Network
